Authors determined that cannabis treatment “was associated with improvements in fibromyalgia-specific symptoms, in addition to sleep, anxiety, and health-related quality of life.”
Region: United Kingdom
“There was no significant association between any measure of cannabis use at baseline and either transition to psychosis, the persistence of symptoms, or functional outcomes,” researchers reported.
“These results suggest that both [cannabis] oils and dried flowers are associated with long-term improved quality of life in chronic pain patients,” investigators concluded.
Cannabis treatment improved sleep- and anxiety-specific symptoms for up to 12 months in patients with chronic illness.
Cannabis treatment was associated with “significant improvements in all primary outcomes … at all timepoints,” authors reported.
Cannabis therapy was associated with sustained improvements in pain, anxiety, sleep, and other health-related outcomes.
Over 90 percent of subjects treated with the combination therapy experienced a ≥50 percent reduction in seizure frequency at six-months.
Six of the seven participants reported “an improvement in symptoms” and “none of the participants reported any adverse side effects.”